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Abstract
It is common for clinicians to implant medical devices, such as permanent pacemakers
and implantable defibrillators, for cardiac diseases. These medical devices require followup care at regular intervals to ensure proper device function and optimal outcomes.
Currently, many individuals without insurance or financial resources lack access to
recommended follow-up care after implantation of a cardiac device. The purpose of this
project was to determine the number of individuals who have had a medical device
implanted without insurance coverage over a 3-year period, and then to establish a clinic
that provides this service. The standard of care and operating procedure for the
pacemaker clinic was established using evidence-based guidelines from the Heart
Rhythm Society and the American Heart Association. Complexity science was the
theoretical model used to guide this project’s design and implementation. This quality
improvement initiative was non-experimental, descriptive, and quantitative. Data were
extracted from the ICD Registry and United States Census Bureau to determine the
number of residents, insurance status, and number of implants over a 3-year period.
These data were used to estimate the number of individuals with devices. The data
revealed that 40 individuals with low power cardiac devices and 15 individuals with high
power devices lacked access to care. The model developed estimates a growth rate of 7
to 10% annually. The pacemaker clinic will provide access to over 70 individuals
lacking care for their pacemakers, thereby resulting in improved healthcare outcomes,
fewer preventable complications, and optimal device performance.
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Section 1: The Pacemaker Clinic
Introduction
Since the 1950s, use of cardiac implantable electronic devices (CIEDs) has gained
acceptance in the cardiology discipline as routine therapy. CIEDs are the standard of care
for many cardiac diseases, including sick sinus syndrome and advanced atrial-nodal heart
block, as well the standard of care as primary or secondary prevention for sudden cardiac
death (Modi, Krahn, & Yee, 2011). Technology has advanced rapidly over the past 20
years, allowing for dramatic reductions in mortality and morbidity for individuals with
chronic cardiac conditions; technology evolved to include defibrillators for the treatment
and prevention of sudden cardiac death (Crozier & Smith, 2012). Cardiac
resynchronization provided hope and extended the lives of countless individuals with
systolic heart failure and other cardiac pacing problems (Modi et al., 2011).
The increased use of CIEDs decreased hospital readmissions for heart failure, thus
providing a financial incentive for their adoption (Noyes et al., 2013). This advanced
therapy has helped control health care cost and promote population health. In addition,
technological advances in the microprocessor industry resulted in cardiac devices with
expanded memory, giving clinicians the information they need to improve patient care.
Expenditures for hospital implantable medical devices increased from $16.1
billion in 2004 to $19.8 billion in 2009 (U.S. Government Accountability Office, 2012).
The implantable device market is growing at a rate comparable to Medicare and
represents a significant portion of total Medicare expenditures (U.S. Government
Accountability Office, 2012). The government payer, the Centers for Medicare, and
Medicare Services (CMS) benefit when CIEDs are monitored after implantation, as
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monitoring reduces the number of unnecessary hospital admissions (Abraham & Hayes,
2003).
Problem Statement
The standard of care requires regular monitoring of CIEDs with in-office
programming or remote follow-up at regular intervals, as recommended by the Heart
Rhythm Society (Tracy et al., 2012; Wilkoff et al., 2008). However, in some locations,
including the area in which this project was conducted, cardiology practices only provide
care for individuals who can pay or have insurance coverage (J. Wesco, personal
communication, March 23, 2014). This policy creates a lack of critical access to care.
Many individuals who received CIEDs urgently through the emergency room or who lost
insurance coverage after implantation cannot obtain the recommended follow-up care,
which often leads to severe complications (Ramsdale & Rao, 2012).
Individuals with high-voltage devices are at greater risk of experiencing
complications from inappropriate shocks from their device, thereby raising mortality
rates by up to 30% (van Rees et al., 2011). The exact cause of the increase in mortality is
not fully understood, but inappropriate events, such as receiving an unnecessary shock,
occur more frequently when follow-up care is lacking (Kleemann et al., 2012).
Complications related to CIEDs are largely avoidable with proper follow-up and care
(Kleemann et al., 2012).
The Heart Rhythm Society recommends regular follow-up for individuals who
have an implantable device (Wilkoff et al., 2008). Most recipients of a pacemaker should
have the device interrogated (the process of acquiring data from the device with
radiofrequency telemetry) at least every 6 months (Wilkoff et al., 2008). For high-voltage
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single-chamber, dual-chamber, or bi-ventricular devices, the recommendation for followup care is every 3 months (Wilkoff et al., 2008). Face-to-face follow-up is essential to the
overall well-being of individuals with implantable devices (Malm & Sandgren, 2014).
Gaps in specialized follow-up care are caused by a lack of financial resources
allocated to individuals with implantable devices who lack private insurance or
government aid (J. Wesco, personal communication, March 23, 2014). All of the
cardiology services in the Kansas City metropolitan area are subsidiaries of hospitalbased organizations. This organizational structure allows cardiology practices to function
in a manner similar to a for-profit corporation, resulting in limited access to individuals
who do not have the ability to pay for their care via third-party or direct reimbursement
(J. Wesco, personal communication, March 23, 2014).
If an individual receives a CIED on an emergent basis, lacks insurance coverage,
or moves into the area with an implantable device, there is no place to obtain needed
follow-up care other than the emergency department (ED). This method is inefficient and
prevents continuity of care. As a result, patients have poor outcomes.
Project Objectives
The primary goal of the pacemaker clinic at the Health Partnership Clinic is to
provide care for all individuals with a CIED, regardless of their ability to pay. The goal of
this project was to identify individuals with devices nearing elective replacement
intervals before the device exhibits end-of-life behavior. Devices nearing the end of their
useable life can trigger symptoms consistent with pre-implantation behavior, including
syncope, chest pain, or in the case of pacemaker-dependent individuals, sudden cardiac
death (Wilkoff et al., 2008).
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Significance/Relevance to Practice
This change project originated in the ED of a local hospital after several
encounters with patients (a) who had pacemakers with preventable complications due to
lack of routine follow-up and (b) who lacked financial means or insurance coverage. In
other cases, individuals received a CIED when they presented for urgent care or they
received a device but did not receive follow-up care due to financial reasons.
The quality improvement plan for a pacemaker clinic was conceived after
conversations with the chief executive officer of the Health Partnership Clinic (HPC).
The HPC is a local clinic that provides services to individuals who have limited or no
ability to pay for services, or who are on Medicaid, which local providers will not accept
for payment. Without sharing patient details that would have compromised
confidentiality, we determined that the HPC had some patients with CIEDs who were
receiving only primary care. They were not receiving follow-up care for their cardiac
needs. Therefore, we decided to assess the need for an extension of services at the HPC
that would include a CIED clinic.
Project Question
Evidence-Based Significance of the Project
Two models were used in this project: the evidence-based practice model (EBPM)
and the Iowa model. The EBPM is a tool for organizing a change project (Gawlinski &
Rutledge, 2008). The Iowa model provides a structured process that assists the project
manager throughout the project (Schaffer, Sandau, & Diedrick, 2013). The Iowa model
incorporates feedback into the evolution of the project and allows for adaptation of ideas
and concepts. Furthermore, the Iowa model is an excellent choice for this highly
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technical subject, CIEDs, which present complex concepts that are difficult to relate to
patient care, even for cardiac specialists unless they have expertise in electrophysiology
(Schaffer et al., 2013). Both models were used to guide all phases of the project,
including decision points.
Implications for Social Change in Practice
Initially, it was estimated that 10–20 individuals would not have insurance or the
financial means to pay for care needed at a pacemaker clinic. Less than 20 people would
be a small number for a full-time clinic. However, initial data revealed a substantial need
in the geographic area for a pacemaker clinic that served individuals with no alternative
for care.
The establishment of a pacemaker clinic designed to serve a vulnerable
population was expected to reduce a gap in care and decrease a significant health
disparity that exists due to financial reasons. By creating this change project and
instituting the Heart Rhythm Society’s standards for care of CIEDs, individuals would
have access to a critical component of care that was currently unavailable (Lampert et al.,
2010). A continuous quality improvement plan was implemented to ensure that quality
care, as measured by the recognized standards, was provided. The priority was to provide
safe care and to improve outcomes.
Definitions of Terms
Cardiac implantable electronic device (CIED): An electronic device that is selfcontained and implantable in a human body (Ellenbogen & Wood, 2008).
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Cardiac resynchronization device: A CIED that provides pacing therapy to the
right and left ventricles, either simultaneously or with offset timing, to treat electrical and
mechanical synchrony in the heart (Ellenbogen & Wood, 2008).
Device interrogation: A process that uses telemetry to retrieve programmed
parameters and data stored in the memory of the device. A dedicated programmer or a
remote server may obtain data (Ellenbogen & Wood, 2008).
Device programming: A non-invasive, stable, reversible change in some of the
operating parameters that enable the provider to select settings to assess and optimize the
system performance and longevity of the CIED (Hays & Friedman, 2008).
Heart failure with preserved ejection fraction: A state of cardiac failure in which
the systolic function is normal or above normal (Hays & Friedman, 2008).
Implantable loop recorder (ILR): A device that stores recordings of the heart
rhythm and data derived from the cardiac rhythm in memory (Ellenbogen & Wood,
2008).
Internal cardiovertor defibrillator: A device that provides therapy, such as highrate pacing or high-energy shock, to either chamber of the heart (Ellenbogen & Wood,
2008).
Pacemaker: A device that provides sensing, pacing, and a response to either
sensing or pacing to the atrium, right ventricle, or left ventricle of the heart (Ellenbogen
& Wood, 2008).
Programmer: A device designed to receive telemetry from a family of devices
made by a specific manufacturer of the CIED. The programmer allows the clinician to
temporarily or permanently adjust CIED programs (Hays & Friedman, 2008).
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Remote follow-up transmitter: A device that transmits information stored in the
CIED to a remote server to which a clinician has electronic access, thereby allowing the
clinician to assess device settings and diagnostics (Ellenbogen & Wood, 2008).
Assumptions and Limitations
Assumptions
It was assumed that data collected from the public domain, the United States
Census Bureau, was accurate. It was necessary to use data in the public domain for this
quality improvement project. Generalizations were assumed based upon this data, as
specific implant data was unavailable.
Limitations
A limitation of the data collected for this quality improvement project was that all
individuals were identified with data available in the public domain; this data may
underestimate the need. Some individuals cared for by the HPC are undocumented
immigrants and they may not have been represented in the census data.
There was no inherent bias in this project. The project was implemented without
the influence of individual device companies, thus there was no commercial influence. Or
conflict of interest. No financial assistance was solicited or accepted from third parties.
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Section 2: Review of Scholarly Evidence
Introduction
The past decade has seen advances in therapies for individuals with cardiac
disease, especially for heart failure and management of arrhythmias. This review of the
literature will focus on the current treatment of heart failure and arrhythmias using
CIEDs. The indications for use and postoperative management of the devices will be the
focus of this review.
Literature Search Strategy
The literature search was conducted using a combined CINAHAL Plus with Full
Text and MEDLINE with Full Text. In addition, the Cochrane Database of Systematic
Reviews was used for meta-analysis. Keywords included: pacemakers, internal
defibrillators, cardiac resynchronization, follow-up, remote, in-clinic, and complications.
This initial search resulted in 3,458 studies. Next, the query was narrowed to the previous
15 years, which left 881 studies. This total was narrowed to studies most relevant,
resulting in 103 articles. Thirty eight studies were most relevant to this quality
improvement project.
General Review of Literature
CIEDs have been around since the 1950s; they are considered the standard of care
for many cardiac diseases (Modi et al., 2011). Technology has improved considerably in
the last two decades and dramatically reduced mortality and morbidity for individuals
with chronic conditions (Crozier & Smith, 2012). From the early pacemakers to the new
defibrillators, CIEDs are used to treat and prevent sudden cardiac death. For example,
cardiac resynchronization has extended the lives of those suffering from systolic heart
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failure (Modi et al., 2011). Some CIEDs provide several kinds of therapy: bradycardia
support, ventricular arrhythmia therapy, heart failure monitoring, arrhythmia monitoring,
and heart failure therapy—all in a single device (Wilkoff et al., 2008).
Expenditures for hospital implantable medical devices, by the Centers for
Medicare and Medicaid Services (CMS) and private insurers, increased substantially in
recent years, from $16.1 billion in 2004 to $19.8 billion in 2009 (U.S. Government
Accountability Office, 2012). These expenditures represent a growth rate in excess of
20%.
After the initial implantation of a CIED, significant follow-up is required to
prevent complications and maximize device function. Udo et al. (2011) conducted a
multicenter randomized cohort study from 2003 to 2007 with 1,517 patients who had
received a CIED. They found that 12.4% of these patients developed complications over
the first 2 months. Thereafter, 9.2% of patients developed long-term complications (Udo
et al., 2012). The researchers were unable to predict who would develop complications.
Follow-up is critical to the proper functioning of a device. However, there
remains considerable debate in the cardiology community about the frequency and type
of follow-up care required for patients with CIEDs (Van Eck et al., 2008). Van Eck et al.
(2008) conducted secondary data analysis to determine the frequency of visits, the
parameters measured during the follow-up, and the training of the personnel involved in
this care. They found that (a) non-physicians perform the majority of these checks and (b)
that crucial parameters were monitored, and appropriate parameter changes made to
prevent device complications.
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The result of pacemaker complications can be severe and dramatic. Ellenbogen,
Wood, and Shephard (2002) found one potential complication. Delayed perforation of the
chamber receiving the pacemaker lead may occur days to weeks after the initial
implantation. If left untreated this can result in the death of the patient. However, this
condition is readily assessable with a routine follow-up and examination by a provider.
Specific Review of Literature
The specific review will focus on the management of individuals postoperatively
after implantation of a CIED. The device specific requirements will be addressed
including pacemakers, defibrillators, and cardiac resynchronization devices. The
indications and required care of these devices along with the training required to provide
this care will be addressed.
Other than patients and their families, who are primary stakeholders in the success
of CIEDs, three organizations are major stakeholders. These organizations monitor and
govern the usage of CIEDs: the American College of Cardiology, the American Heart
Association, and the Heart Rhythm Society. These organizations work with the Food and
Drug Administration and the CMS to approve and monitor devices and set payment
parameters. Members of these organizations conduct research studies and the results of
the studies are published in peer-reviewed journals. Professionals from many disciplines
work together to provide guidelines for device usage that help clinicians care for cardiac
patients needing CIEDs.
General Follow-Up Considerations
All CIEDs, regardless of the type, have follow-up requirements. The four
objectives in follow-up are patient-related considerations, device-related considerations,
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disease-related considerations, and communication-related considerations (Wilkoff et al.,
2008).
Patient-related issues. The primary objective of CIED follow-up is to optimize
individuals’ quality of life and to minimize the impact the device has on individuals’
daily life activities. This goal is accomplished ensuring the system functions to meet each
individual’s needs. Time spent during the follow-up interaction also gives the clinician an
opportunity to identify other health issues that may need attention.
Device-related issues. This goal includes the documentation of device function.
When device function is abnormal, clinicians take corrective action. Monitoring the
device is documented throughout the lifespan and planning for device succession occurs
before failure of the device.
Disease-related issues. Diagnostics collected by the device provide insight into
disease progression and the specifics needed to provide optimal care. Device follow-up
sessions provide the clinician with access to this information. Clinicians can access and
share this information with multidisciplinary team members.
Communication issues. CIEDs require a line of communication remain in place
between manufacturer, clinician, and patient. Issues might arise with specific models
from the device manufacturer, necessitating the sharing of information. Patients need
access to their clinician, clinicians need access to the manufacturer, and the manufacturer
needs access to patients via clinicians.
Indications for Implantation
The American College of Cardiology, American Heart Association, and the Heart
Rhythm Society adopted the following guidelines for CIED implantation based upon
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evidence class (Epstein et al., 2013): Class I conditions are those for which pacing
treatment is definitely beneficial and necessary to prolong life. Examples of Class I
conditions include heart blockage, asystole, or bradycardia that is hemodynamically
compromising to an individual. Class II conditions are those in which pacing may be
indicated, but there is some conflicting evidence or divergence of opinion. Class III
conditions are those for which pacing may or may not be useful and may be potentially
harmful.
Low-Powered CIED
Indications. Indications for low-powered devices or pacemakers include rhythmrelated reasons, high-degree atria-nodal blockage, and symptomology. Symptoms related
to heart rate include dizziness, lightheadedness, syncope, fatigue, poor exercise tolerance,
and chest pain (Modi et al., 2011). Pacemakers may be dual-chamber devices with a lead
into the right atrium and left ventricle, or single-chamber pacemakers with one lead into
either the atrium or ventricle (Modi et al., 2011).
Follow-up considerations. Low-powered devices require follow-up at regular
intervals. The first in-person follow-up should be within 72 hours of device implantation
(Wilkoff et al., 2008). Parameters to be assessed include battery status, lead performance,
pacing and sensing thresholds, and the diagnostics of these primary indicators. After this
initial contact, follow-up should occur between 2 and 12 weeks. After this contact,
follow-up can be every 3 months if remote follow-up is activated. In-clinic follow-up
should occur no less than every 12 months (Wilkoff et al., 2008). As device longevity
approaches elective replacement levels, follow-up is necessary at monthly intervals until
the device (or a component thereof) is replaced (Wilkoff et al., 2008).
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High-Powered CIED
The role of the implantable defibrillator has increased over the last 20 years.
Initially, these devices were implanted for survivors of two episodes of sudden cardiac
death (Greenberg et al., 2004). During the 1990s, the indications were expanded to
include primary prevention of sudden cardiac death (Greenberg et al., 2004). Large
multicenter studies such as MADIT and MADIT II demonstrated superior survival rates
compared to traditional medication therapy (Greenberg et al., 2004). Devices have
become smaller, more efficient, and safer over the years.
Indications. Indications for high-voltage devices are either primary prevention
based upon heart function and risk factors or secondary prevention for sudden cardiac
death. The major risk factor for sudden death is structural heart disease, either from
coronary artery disease (ischemic) or other forms of cardiomyopathy not related to
coronary artery disease (non-ischemic) (Desai, Fang, Maisel, & Baughman, 2004).
Researchers demonstrated a significant reduction in mortality from the use of ICDs in
both forms of structural heart disease (Desai et al., 2004; Greenberg et al., 2004).
Follow-up considerations. High-powered device follow-up requirements are
similar to follow-up requirements to low-powered devices, with additional requirements
unique to these devices. Clinicians monitor battery status, lead performance, pacing and
sensing thresholds, high-voltage capacitor functioning, and charge time. The high-voltage
functioning feature is the most important function of a high-voltage device.
Cardiac Resynchronization CIED
As the burden of heart failure has increased for individuals and society, new
methods to treat this progressive disease have been developed (Abraham & Hayes, 2003).
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One such therapy is cardiac resynchronization therapy (CRT). The CRT CIED provides
electrical stimulation in multiple areas of the ventricle for individuals experiencing
mechanical problems; such problems often lead to severe complications (Ramsdale &
Rao, 2012).
Indications. The indications for CRT are heart failure, New York III or IV class,
systolic dysfunction, and prolonged ventricular depolarization (QRS greater than 140ms;
Burkhardt & Wilkoff, 2007). These indications were revised over the past several years
and have become more restrictive in response to the ongoing debate over the long-term
benefit for some populations.
Follow-up considerations. In addition to the follow-up needed for both low- and
high-powered CIEDs, CRT CIEDs are used to treat heart failure. These devices have
additional diagnostics capabilities that help clinicians assess fluid volume. This CRT
CIEDs feature requires nearly constant monitoring. To address the need for nearly
constant monitoring, remote monitoring is active at all times in the devices; outside of the
hospital, the device maintains communication with home units that have Internet access.
An alert triggered in the device by a cardiac event is sent to a database and then
forwarded to the individual’s clinician for review.
Multidisciplinary Relationships
Given the complexity of CIEDs, it may be necessary to obtain technical support
for an individual’s care (Hayes, Juknavorian, & Maloney, 2001). Industry allied
professionals are individuals with industry training that may be certified by the
International Board of Heart Rhythm Examiners. The Heart Rhythm Society also
recognizes allied professionals; these professionals provide patient care (Hayes et al.,
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2001). It is important to maintain awareness of the conflict of interest that is inherent
when a device manufacturer employs a care provider. Decisions regarding patient care
should occur in the absence of conflicts of interest. While technical advice can be sought,
healthcare providers tasked with caring for the patient best make decisions that affect
patients.
Adverse Events
For patients who receive a CIED, the standard of care requires regular monitoring
of these devices with in-office programming or remote follow-up at regular intervals, as
recommend by the Heart Rhythm Society (Tracy et al., 2012; Wilkoff et al., 2008).
Remote Follow-Up
One of the most significant changes with regard to monitoring of CIEDs is remote
follow-up using the Internet. This change occurred rapidly. While programming or
changing settings is unavailable via the telephone or Internet, almost every piece of
information stored in the device can be transmitted into a database accessible by
clinicians in real time. It is important for patients with a CIED to be aware of negative
information related to their CIED. In the case of individuals with atrial fibrillation at risk
for stroke who cannot be anti-coagulated, remote follow-up can be used to detect this
rhythm disorder and notify the healthcare provider about this abnormality (Gimbel,
2012). When an individual has a normal heart rhythm, there are no transmissions, thus
indicating no need for intervention. Remote follow-up used in conjunction with
traditional in-office follow-up also offers improved productivity for clinics that adopt this
method (Cronin et al., 2012). More importantly, outcomes improve for patients who have
remote capabilities and traditional office follow-up visits (Cronin et al., 2012).
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Theoretical Framework
The way healthcare is provided in the United States works well for a few
individuals, however there remain a substantial number of people without insurance or
the ability to pay for healthcare. Since early 2014, the healthcare system has not been
functioning as intended. As such, theory based upon a nonlinear worldview is best for
research into a phenomenon as complex as the healthcare system. Traditional linear
thinking, in which the input equals the output or the size of the input is equal to the size
of the output, must be replaced with the understanding that small changes can create great
change. Complexity science (CS) describes phenomena as they are rather than how they
should be.
Simple agents, or initiatives, that are basic units following simple rules can
generate complex structures (Paley, 2007). The relationship between these simple agents
defines CS. Paley (2007) used CS and the understanding of complex adaptive systems
(CASs) to determine why a cardiac rehabilitation unit was not receiving referrals. Paley
(2009) identified many individual elements that were not considered complex issues but
that, in aggregate, formed a bottleneck for referrals to this service. Using complexity
analysis, Paley developed a new system that satisfied the needs of all stakeholders.
For a project that is multidisciplinary, using facilities from primary to tertiary
care, and crossing many specialty practices, the Iowa model is not sufficient as a standalone mode. It serves well as the model for data collection, however a more
comprehensive theory must be used in conjunction to capture the complete theme of the
project. CS provides a patient centered model that helps define chaos and translate to
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meaningful change in organizations (Hast, DiGioia, Thompson, & Wolf, 2013). It is well
suited for the development of a pacemaker clinic.
Definition of Complexity Science
CS is neither a single theory nor exclusively a nursing theory; it is an
interdisciplinary field recognizing multiple theoretical frameworks (Zimmerman,
Lindberg, & Plsek, 2001). Lindberg, Nash, and Lindberg (2008) defined CS as
“examining systems comprised of multiple and diverse interacting agents and seeking to
uncover the principles and dynamics that affect how such systems evolve and maintain
order” (p. 78). Zimmerman et al. (2001) stated that CS gives “a description of the
complex phenomena demonstrated in systems characterized by nonlinear components,
emergent phenomena, continuous and discontinuous change, and unpredictable
outcomes” (p. 112).
Concepts of Complexity Science
CS recognizes that individuals, businesses, hospitals, and all systems are CASs.
The word complex implies diversity and a great number of connections between wide
varieties of elements; adaptive refers to the capacity to alter or change and the ability to
learn from experience; and system refers to a set of connected or interdependent things
(Zimmerman et al., 2001). CASs have many interconnected, interdependent, adaptive,
and diverse elements, each of which may be a CAS (Lindberg et al., 2008). Diversity is
essential for CASs because diversity allows for adaptation when confronted with a
challenge. The interdependent nature of CASs is evidence that an individual cannot
survive in isolation.
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The eight major properties of CASs include diversity, self-organization,
embeddedness, distributive control, nonlinear dynamics, adaptable elements, emergence,
and the coexistence of order and disorder (Lindberg et al., 2008). A definition of each
property is provided below.
Diversity. CASs are composed of heterogeneous parts in the system. Diverse
elements enable the system to function at a higher level and outperform homogeneous
groups.
Self-organization. CASs are subject to influence from many forces within and
outside of the CAS that may create novel patterns, structures, and processes. Simply put,
there is no such thing as a static CAS.
Embeddedness. Each agent is itself a CAS, as well as a part of all CASs that, in
turn, make up a larger CAS. There is no such thing as isolation in CS and there is no
insignificant CASs. Every individual may have great, little, or no impact on the larger
CAS.
Distributive control. The concept of individual control does not exist within a
CAS. Many agents formally and informally share control. Diversity is at the center of
control in a CAS.
Non linear dynamics. The effect of a change agent in a CAS is difficult to
predict. This unpredictability is due to the non-linear behavior of a CAS. Small changes
may have large effects in a CAS, but can have proportional effects or no change at all.
This condition is in stark contrast to linear theories, which state the output is equal to the
input.
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Adaptable elements. For a CAS to survive, it must be adaptable and have
elements within the global CAS that are able to adapt. Biological species have the ability
to modify themselves to survive the evolutionary process. CASs possess the ability to
survive as organizations.
Emergence. CASs are not static organizations creating new and unexpected
structures, patterns, or processes within the overall system. Emergents can take on a life
of their own and create their own rules.
The coexistence of order and disorder. It is not essential for a CAS to have
order. Instead, a CAS can thrive with or without order because the normal state of a CAS
includes order and disorder.
Complexity Science and Nursing
The embedded principles of CS are evident in nursing practice. A schism exists,
however, between practice and nursing theory. Current nursing theory has been
predominantly derived from a linear worldview rather than from a dynamic, unitary
worldview. Lindberg et al. (2008) suggested linear theories are detrimental to nursing
education and negatively influence all aspects of nursing. CS provides an alternative to
linear thinking and theorizing. It is a complementary perspective to facilitate describing,
understanding, and using nursing theories that are compatible with nursing concepts and
constructs (Lindberg et al., 2008). Using the concepts of CS to guide nursing research is
the next logical step.
Complexity science provides a comprehensive framework to understand and
navigate complex adaptive systems. The healthcare system, which has many adaptive
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parts, is dynamic and in a constant state of change. This framework defined and captured
the complex themes that guided this project.
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Section 3: Methodology
Introduction
This study was designed to provide the necessary information to quantify the
scope of the problem facing individuals lacking access to care who have an implantable
cardiac device. The methods used to document the need will be covered in detail. Data
from the Centers for Medicaid and Medicare Services, the United States Census Bureau,
and the Health Partnership Clinic were used to develop a historical and predictive model
to predict need.
Approach
Project Design
This quality improvement project used a non-experimental, descriptive,
quantitative research design. It involved the secondary analysis of archival data, data
provided by the Health Partnership clinic without patient identifiers or proprietary data.
Population and Sampling
U.S. Census Bureau data included the number of individuals residing in the
geographical area, individuals who lost access to health insurance coverage in any given
year, and the total number of device implants as reported to the Centers for Medicaid and
Medicare. Descriptive analysis was used to determine the number of patients who had
implantable devices but lacked access to care.
Two types of data were collected: the actual number of implantable devices and
the insurance status of residents in the area. No patient identifiers were associated with
this data. Inclusion criteria were as follows: CIED implants in Johnson County, Kansas,
for the years 2010, 2011, and 2012. Insurance status for the general population was
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obtained from U.S. Census Bureau data and used as a baseline to estimate the number of
uninsured with an implantable device.
Methods for Safeguarding Human Subjects
Data were obtained after approval from the Walden University Institutional
Review Board (12-01-14-0307415). Because no patient identifiers were included in the
data, there was no risk associated with unauthorized use of the data or violations of
confidentiality. No human subjects were involved in the collection of this data.
Ethical Issues
The concept of autonomy is one of the guiding principles of ethical care
(American Nurses Association, 2001). Autonomy allows all competent individuals to
refuse any or all treatment provided. Refusal of treatment can be a difficult situation
when the device is implanted improperly and cannot be easily removed from the
individual’s body (Kobza & Erne, 2007). Cultural and religious beliefs may influence
individuals’ healthcare decisions. Ethical issues are relevant for individuals with
implantable devices and these devices often provide therapy needed to live (Kobza &
Erne, 2007). For some individuals, withdrawal of therapy results in immediate death.
Withdrawal of basic support is controversial and can be considered euthanasia. The
individual ultimately controls his or her own destiny and others should respect the
autonomy of this right.
At end of life, a patient may wish to terminate therapies provided by the device.
When this situation occurs, the provider must have a thorough discussion with the patient
and family. The provider must not project his or her values when a patient decides to
cease therapy.
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There are no human subjects in this quality improvement project. There are no
patient identifiers associated with any data collection. The archival data collected was
anonymous and was stored on the investigators computer. The raw data will be
destroyed at the conclusion and publication of this project. The project was undertaken at
a clinical site and no incentives were associated with this project.
Data Analysis Strategies
The total numbers of CIEDs were tallied along with the likely number of
individuals with CIEDs who might lack access to care, based upon implant numbers from
the ICD registry. Patient-specific indicators including age and gender were obtained. The
analyses included comparisons of means and the total number of identified individuals.
Project Evaluation Plan
Evaluation Strategies
The first step in this study was to review the literature on an ongoing basis to
compare actual performance of the clinic with evidence-based studies and consensus
practice. This information was used to ensure that, in the rapidly changing environment
of clinical care, the clinic will follow and maintain best practices. A systematic qualitymonitoring plan was created as an addition to the ongoing quality program in place at the
HPC to monitor a random sample of patient encounters to ensure that standards are
followed.
New Practice Guidelines
Guidelines for practice fall into three categories: pacemakers, defibrillators, and
CRT devices. A set of protocols was established for each implantable device. The
standard format is similar, in that remote monitoring is used whenever possible, given the
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technical and communication limitations some individuals face. Patient checks are
scheduled every 90 days for all types of devices, with remote checks being allowed for 3
of 4 annual checks for pacemakers. For high-voltage devices, remote checks can be used
biannually, with one in-clinic check performed every 6 months.
For individuals on antiarrhythmic medication, more frequent follow-up may be
recommended on an individual basis (Wong, Yu, & Holbrook, 2010). For individuals
receiving high-voltage therapy, consultation with a local electrophysiologist or
cardiologist specializing in the care of patients with these devices is needed to ensure
optimal medical management (Lampert et al., 2010).
For clinic patients taking antiarrhythmic medication, an alert was built into the
electronic record. This alert will make primary care providers and staff aware of the
potential serious drug interactions that some medications, especially antibiotics, might
have on the conduction system of the heart when an ADD is being used.
New Standards of Care at the HPC
Patients visiting the HPC for medical device follow-up can expect to receive care
provided at traditional pacemaker clinics. The Heart Rhythm Society is the organization
that guides private and public payers’ treatment of heart rhythm disorders. This
organization works closely with the U.S. Food and Drug Administration and the suppliers
of medical devices to monitor and report potential adverse outcomes related to devices
already implanted. The Heart Rhythm Society sets the care and follow-up standards for
care of CIEDs.
The Heart Rhythm Society recognized the role of the non-physician provider in
the care of CIEDs and issued a policy statement to detail the qualifications and standards

25
of care (Gura et al., 2003). The core knowledge and skills are detailed in this position
statement including: Core Knowledge, Core Standards and Elements, Rhythm
Management, and Follow-up (Gura et al., 2003). The International Board of Heart
Rhythm Examiners (IBHRE) offers certification as a Cardiac Electronic Device
Specialist (CEDS) to eligible candidates to document their knowledge (Gura et al., 2003).
The staff performing follow-up interrogations at the Health Partnership Clinic will be
required to have this CEDS certification.
Project Strengths and Limitations
Analysis of Self
The role assumed by the project manager/student was comprehensive: scholar,
manager, practitioner, administrative and cheerleader. The most significant contribution
made was to create an atmosphere where the need for this service was appreciated and
with resulting social change. The easy part was to provide the service. The development
of the project required patience and extensive management of resources. It was very
gratifying to make multiple presentations to the board of directors with a positive
outcome.
Summary
This project, when fully implemented will provide evidence base care to a
vulnerable population with cardiac devices. This specialized care is not available to
residents in the geographical area at this time. Thus, a critical need will be filled as a
result of this project, resulting in positive and meaningful social change.

26
Section 4: Findings, Discussion and Implications
Findings
Johnson County, Kansas, experienced a decline in the population from 2011 to
2012; however, the population grew in 2013 to 417,507 individulals (United States
Census Bureau, 2014). Given this variability, the poplulation of adults over the age of 18
for 2001–2013 was used for this study: 407,669 (United States Census Bureau, 2014).
Table 1
Number of Adults in Johnson County, Kansas by Age
Year

18– 65

Over 65

Total

years of age

years of age

population

2011

344,936

59,743

404,679

2012

341,501

59,322

400,823

2013

350,577

66,930

417,507

2014

345,671

61,998

407,669

Number of CIED Implants in Johnson County, Kansas
The number of total implants was obtained from St. Jude Medical’s marketing
department (C. Peltz, personal communication, December 08, 2014). This information is
available via request and is acquired from industry data and publically reported financial
reports. The total number of low power implants averaged 728 per year for the years
2011 to 2013. The total number of high power implants for the same time period was
718, averaging 239 per year. There was a slight contraction in implants during this time
period, so the average of the 3 years was used for this study.
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Table 2
Number of Low and High Powered Medical Device Implants for Johnson County, Kansas
Year

Number of Low Voltage

Number of High Voltage

Implants

Implants

2011

732

263

2012

762

253

2013

679

202

Total

2,183

718

Number of Uninsured Johnson County Residents
The number of uninsured residents in Johnson County remained steady during
the years 2011 to 2013 and averaged 21,730 uninsured adults between the ages of 18 and
65 (United States Census Bureau, 2014). Very few of the individuals over 65 had
minimal insurance through Medicare. What is not known is the number of individuals
lacking Medicare Part D and the number unable to afford physician visits. The researcher
assumed that they were represented in this number with an average of 85 individuals
annually.
Table 3
Number of Uninsured Residents in Johnson County
Year

Between 18 – 65 Years of

Over 65 Years of Age

Age
2011

22,225

175

2012

21,607

39

2013

21,358

42

Average

21,730

85
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Implant Demographics
The number of CIED implants increases significantly with age. The exact number
of non-Medicare implants is unavailable in the public domain and local hospitals consider
this information proprietary and will not disclose the exact numbers. The largest study
that tracks medical device implants by age is the ICD registry sponsored by the Heart
Rhythm Society and the American College of Cardiology Foundation (Kremers et al.,
2013). This registry has over 850,000 participants and represents the most comprehensive
database for CIED implants in the United States (Kremers et al., 2013). This database
represents hospitals’ voluntary reporting, which has the possibility to not accurately
represent the data. The data from this registry demonstrated that 35% of CIED implants
occur in the under 65 age group, thus this number was used given the assumption that
individuals in the under 65 age group receive CIED implants.
Table 4
CIED Implants per Thousand of Total Population
Year

Low Voltage

High Voltage

2011

1.809

0.650

2012

1.901

0.631

2013

1.626

0.484

Average

1.779

0.588

Estimated Number of Noninsured Individuals Receiving CIEDs
Using the assumption of the ICD registry, that 35% of CIED implants occur in the
under 65 age group and no hospital in the county provides pediatric services, the number
of implants per 1000 individuals was applied to the 18 to 65 population with the
assumption that 35% of the total implants in the county occurred in this group. This was
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then applied to the uninsured group to estimate the total number of implants for both lowand high-voltage devices.
Table 5
Number of Potential Individuals with CIEDs Lacking Access to Care Over the Past 3
Years Based Upon 35% for Age 18-65 and 65% Over Age 65
Year

Between ages 18 – 65 years

Over 65 Years of age

Low Voltage

High Voltage

Low Voltage

High Voltage

2011

14

5

<1

<1

2012

13

5

<1

<1

2013

13

5

<1

<1

Total

40

15

<1

<1

It is estimated that 13 low-voltage implants, along with 5 high-voltage implants,
occur in the uninsured population annually in Johnson County. The number of implants
in the over 65-age group is less than one annually. This finding is consistent with
information provided by the Health Partnership patient database. Given that the average
life of a CIED is 5 years and the average length of patient relationships at the Health
Partnership Clinic, it is likely that there are currently 40 individuals with low-power
devices and 15 individuals with high-power devices lacking recommended care. This
number is likely to grow as Kansas has elected not to extend Medicaid benefits to this
group of patients.
Discussion
The total population lacking medical care for their implanted devices in Johnson
County, Kansas, is substantial. Using the assumptions from the United States Census
Bureau and the ICD registry, it can be accurately predicted the number of individuals
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lacking care is a significant and stable size. The recent implementation of the Affordable
Care Act is not likely to change this need, as Kansas has not expanded Medicaid
eligibility.
Implications
For individuals lacking access to care with an implantable CIED the ramifications
can be catastrophic. Seniors complications can and often occur without proper follow up
care. For local institutions the financial implications can be considerable. With the
average emergency department visit for a CIED complication costing $12,000, it only
takes a few preventable complications to have a significant impact (S. Elsey, personal
communication, December 6, 2014). The availability of care will enhance individuals’
lives and provide a place for medical care. This will result in positive social change for
over 50 residents of Johnson County within the first few months of this clinic’s
formation.
Summary and Conclusions
There is a definite need for social change in Johnson County Kansas to provide
access to care to uninsured, undocumented, and individuals without the ability to pay for
specialty cardiac care. Many individuals that have implantable cardiac devices cannot
achieve full health without access to care. This project identified this need and provided
a workable solution. Using skills learned in the terminal degree program for the Doctor
of Nurse Practice, a program to address this need was successfully developed, funded,
and implemented. Many individuals will now have access to this care that previously did
not.
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The Creation of a Pacemaker Clinic at a Federally Funded Patient Centered Medical
Home as a Quality Improvement Project
Since the 1950s, use of cardiac implantable electronic devices (CIEDs) gained
acceptance in the cardiology realm as routine therapy. CIEDs are the standard of care for
many cardiac diseases, including sick sinus syndrome, advanced atrial-nodal heart block,
and as primary or secondary prevention for sudden cardiac death (Modi et al., 2011).
Technology has advanced rapidly, allowing for dramatic reductions in mortality and
morbidity for individuals with chronic cardiac conditions (Crozier & Smith, 2012). From
the humble pacemaker, technology evolved to include defibrillators for the treatment and
prevention of sudden cardiac death.
Expenditures for hospital implantable medical devices increased from $16.1
billion in 2004 to $19.8 billion in 2009 (U.S. Government Accountability Office, 2012).
The implantable device market is growing at a rate comparable for Medicare and
represents a significant portion of total Medicare expenditures. The government payer,
the Centers for Medicare and Medicare Services (CMS), benefits when CIEDs are cared
for after implantation by reducing unnecessary hospital admissions.
Cardiac resynchronization has provided hope and extended the lives of countless
individuals with systolic heart failure and other cardiac pacing problems (Modi et al.,
2011). The increased use of CIEDs also helped decrease readmissions for heart failure,
thus providing a financial incentive for their adoption (Noyes et al., 2013).
Project Objectives
The goal of the pacemaker clinic at the Health Partnership Clinic is to provide
access to care for all individuals with a CIED regardless of their ability to pay. This
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change will result in an increased quality of care, as evidenced by complication rates
consistent with the national average for individuals receiving care in traditional
pacemaker clinics. The secondary goal of this project was to identify individuals with
devices nearing elective replacement intervals before the device exhibits end-of-life
behavior.
Significance/Relevance to Practice
On multiple occasions, individuals present to local Emergency Departments with
preventable device complications from lack of routine follow-up. In some cases,
individuals lost their insurance and could no longer afford clinic visits. In other cases,
individuals receive a CIED when presenting for urgent care, yet do not receive follow-up
care. The common thread is these individuals are unable to obtain follow-up care,
primarily due to financial reasons.
A pacemaker clinic was conceptualized after conversations with the Chief
Executive Officer of the Health Partnership Clinic (HPC), a local clinic that provides
services to individuals with limited or no ability to pay for services, or Medicaid, which
local providers will not accept for payment. Local practices have limited space for these
patients to receive care (Health Care Partnership, 2014). Without sharing patient details
that would have compromised confidentiality, we determined that the Health Care
Partnership had some patients receiving primary care with CIEDs. These patients were
not receiving follow up care for their cardiac needs. As such, we decided to assess the
need for an extension of services at the HPC to include a CIED clinic.
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New Standards of Care at the HPC
Patients visiting the HPC for medical device follow-up can expect to receive care
provided at traditional pacemaker clinics. The Heart Rhythm Society is the organization
that guides private and public payers’ treatment of heart rhythm disorders. This
organization works closely with the U.S. Food and Drug Administration and the suppliers
of medical devices to monitor and report potential adverse outcomes related to devices
already implanted. The Heart Rhythm Society sets the care and follow-up standards for
care of CIEDs.
The Heart Rhythm Society has recognized the role of the non-physician provider
in the care of CIEDs and issues a policy statement to detail the qualifications and
standards of care (Gura et al., 2003). The core knowledge and skills are detailed in this
position statement including: Core Knowledge, Core Standards and Elements, Rhythm
Management, and Follow-up (Gura et al., 2003). The International Board of Heart
Rhythm Examiners (IBHRE) offers certification as a Cardiac Electronic Device
Specialist (CEDS) to eligible candidates to document their knowledge (Gura et al., 2003).
The staff performing follow-up interrogations at the Health Partnership Clinic will be
required to possess this certification.
Number of CIED Implants in Johnson County Kansas
The number of total implants was obtained from industry information from St.
Jude Medicals marketing department (C. Peltz, personal communication, December 8,
2014). This information is available to the public via request. The total number of low
power implants average 728 per year for the years 2011 to 2013 . The total number of
high power implants for the same time periord was 718, averaging 239 per year . There
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was a slight contraction in implants during this time period, so the average of the three
years will be used for this study.
Number of Uninsured Johnson County Residents
The number of residents in Johnson County remained steady during the years
2011 to 2013 and averaged 21,730 for adults between the ages of 18 to 65 (United States
Census Bureau, 2014). For individuals over 65 there were very few individuals not
having minimal insurance through Medicare. What is not known is the number of
individuals lacking Medicare Part D and not able to afford physician visits. The
assumption will be made that they are represented in this number with an average on 85
individuals annually.
Implant Demographics
The number of CIED implants increases significantly with age. The exact number of
Non-Medicare implants is not available in the public domain. Local hospitals consider
this information proprietary and will not disclose the exact numbers. The largest study
that tracks medical device implants by age is the ICD registry sponsored by the Heart
Rhythm society (Kremers et al., 2013). This registry has over 850,000 participants and
represents the most comprehensive database for CIED implants in the United States
(Kremers et al., 2013). This registry demonstrated that 35% of CIED implants occur in
the under 65 age group, thus this number will be used in the assumptions of individuals
receiving CIED implants in this demographic.
Estimated Number of Non Insured Individuals Receiving CIEDs
Using the assumption of the ICD registry, that 35% of CIED implants occur in the
under 65 age group, and no hospital in the county provides pediatric services, the number

42
of implants per 1000 individuals will be applied to the 18 to 65 population with the
assumption that 35% of the total implants in the county occurred in this group. This will
then be applied to the uninsured group to estimate the total number of implants for both
low and high voltage devices.
It is estimated that 13 low voltage implants, along with 5 high voltage implants,
occur in the uninsured population annually in Johnson County. The number of implants
in the over 65-age group are less than one annually. This finding is consistent with
information provided by the Health Partnership demographics. Given that the average life
of a CIED is 5 years, and the average length of patient relationships at the Health
Partnership Clinic, it is likely that there are currently 40 individuals with low power
devices, and 15 high power devices lacking recommended care. This number is likely to
grow as Kansas has elected not to extend Medicaid benefits to this group of patients.
Implications
For individuals lacking access to care with an implantable CIED the ramifications
can be catastrophic. Serious complications can and often occur without proper follow-up
care. Local institutions risk considerable financial implications of providing mandated
care to the uninsured population. The average emergency department visit for a CIED
complication costing $12,000 in this area. It only takes a few preventable complications
to have a significant impact on local hospitals (S. Elsey, personal communication,
December 6, 2014). For individuals, the availability of care will enhance their lives
physically and provide the emotional security of a medical home. Positive social change
resulted for over 50 residents of Johnson County within the first few months of this
clinics formation.
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